Presented by:
Elizabeth Miazga
Affiliations:
University of Toronto
Watch on YouTube
https://youtu.be/xdqSjb3DJSw Click here to watch this video on YouTube.
What is a Mid-Urethral Sling?
A mid-urethral sling is a minimally invasive surgical treatment for stress urinary incontinence, a condition in which urine leaks during activities that increase abdominal pressure, such as coughing, sneezing, exercising, or lifting. The procedure places a narrow strip of synthetic mesh beneath the middle portion of the urethra to provide additional support. The two primary approaches are retropubic and transobturator, which differ in the pathway used to position the sling. Here’s what it involves:
- Vaginal Incision: A small incision is made in the vaginal wall beneath the mid-urethra to provide access for sling placement.
- Tissue Dissection: A controlled pathway is created alongside the urethra for passage of the sling instruments.
- Sling Passage: The mesh is passed along either a retropubic trajectory behind the pubic bone or a transobturator trajectory through the obturator region.
- Anatomical Awareness: Important structures along the selected pathway are identified and avoided, including major blood vessels with the retropubic approach and the obturator neurovascular structures with the transobturator approach.
- Sling Positioning: The mesh is positioned beneath the mid-urethra to provide support during increases in abdominal pressure.
- Tension Adjustment: The sling is carefully positioned without excessive tension to support continence while allowing normal urination.
- Final Assessment: The surgical area is inspected and, when appropriate, cystoscopy is performed to assess the bladder and urethra before completing the procedure.
Both approaches aim to restore support to the mid-urethra while minimizing tissue disruption and allowing relatively rapid recovery.
What are the Risks of a Mid-Urethral Sling?
Mid-urethral sling surgery is generally minimally invasive, but its proximity to the bladder, urethra, blood vessels, nerves, and other pelvic structures creates specific potential complications.
- Bladder or Urethral Injury: Sling instruments can inadvertently enter or injure the bladder or urethra, particularly during retropubic placement.
- Bleeding or Vascular Injury: The retropubic approach passes near important pelvic blood vessels, creating a risk of bleeding or hematoma formation.
- Nerve or Vascular Injury: Transobturator sling placement occurs near the obturator neurovascular bundle and may result in nerve or blood vessel injury.
- Urinary Retention or Difficulty Urinating: A sling that is too tight or postoperative swelling may make bladder emptying difficult and occasionally require further treatment.
- Mesh Exposure or Erosion: Synthetic mesh can become exposed through the vaginal tissue or, less commonly, erode into nearby urinary structures.
- Groin or Pelvic Pain: Pain can occur after either approach, with groin or thigh discomfort particularly associated with the transobturator trajectory.
- Urinary Symptoms: Some patients may develop new or worsening urinary urgency, frequency, or urge incontinence after surgery.
- Infection: Urinary tract, vaginal, or surgical-site infections can occur following the procedure.
- Persistent or Recurrent Incontinence: The procedure may not completely resolve stress urinary incontinence, or symptoms may recur over time.
- General Surgical Risks: Blood clots, anesthesia-related complications, wound problems, and rarely injury to other pelvic or abdominal structures are possible.
A detailed understanding of pelvic anatomy, correct sling trajectory, careful instrument passage, and appropriate tensioning help reduce these risks while providing effective support to the mid-urethra.